News from abbott A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

17 Sep, 2019, 14:00 BST Abbott Announces European Approval of Two Life-saving Heart Devices for Babies and Children

Abbott (NYSE: ABT) today announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP™ 15mm rotatable mechanical heart...


16 Sep, 2019, 16:45 BST Abbott Named the Industry Leader in Sustainability for the Seventh Consecutive Year on the Dow Jones Sustainability Index (DJSI)

Abbott (NYSE: ABT) has been named the Global Industry Leader in sustainability for the seventh consecutive year by the Dow Jones Sustainability Index ...


10 Sep, 2019, 14:00 BST Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients are Having a Heart Attack

Abbott (NYSE: ABT) announced today that new research, published in the journal Circulation, found its algorithm could help doctors in hospital...


26 Aug, 2019, 12:00 BST Together, We Can Increase the Number of Women in STEM: Here is a Tool to Help Companies Get Started

We know the facts: Girls are less likely to be encouraged to study science, technology, engineering and math. Women who do pursue STEM degrees often...


20 Feb, 2019, 13:00 GMT Abbott Introduces the World's Most Sensitive Rapid Diagnostic Test, Determine™ HBsAg 2, to Accelerate Hepatitis B Care

Abbott (NYSE: ABT) announced today it has received CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B...


14 Dec, 2018, 16:19 GMT Abbott Raises Quarterly Dividend 14%, Increasing Payouts for 47 Straight Years

The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 32 cents per share, marking a 14 percent...


11 Dec, 2018, 14:00 GMT Abbott to Present at J.P. Morgan Healthcare Conference

Abbott (NYSE: ABT) will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2019. Brian Yoor, executive vice president...


14 Nov, 2018, 14:00 GMT Abbott Recommends Rejection of Below-Market Mini-Tender Offer by Baker Mills LLC

Abbott (NYSE: ABT) received notice of an unsolicited mini-tender offer by Baker Mills LLC (Baker Mills) to purchase up to 60,000 Abbott common...


01 Oct, 2018, 13:00 BST Abbott′s FreeStyle® Libre 2, with Optional Real-Time Alarms, Secures CE Mark for Use in Europe

People living with diabetes in Europe will now have the choice to be alerted in real-time of hypoglycemia (low glucose levels1) or hyperglycemia...


23 Apr, 2018, 14:00 BST Sanquin Selects Abbott's "Alinity™ s" Solution for Blood and Plasma Screening

Sanquin and Abbott (NYSE: ABT) announced today that they signed a multiple-year contract for the supply of primary serological equipment and...


20 Apr, 2018, 15:10 BST Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023

Abbott (NYSE: ABT) and the World Marathon Majors today announced the renewal of Abbott's title sponsorship. The partnership will extend into 2023,...


11 Apr, 2018, 14:00 BST Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in Treating Coronary Artery Disease

- Largest-ever randomized trial to evaluate superiority of light-based, three-dimensional imaging (optical coherence tomography (OCT)) versus...


30 Oct, 2017, 17:20 GMT Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery

Abbott (NYSE: ABT) today announced that patients who underwent minimally-invasive implantation with a XIENCE coronary stent for left-main coronary...


30 Oct, 2017, 11:00 GMT Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]

Abbott (NYSE: ABT) today announced it received CE Mark for XIENCE Sierra, the newest generation of the company's gold-standard XIENCE...


16 Oct, 2017, 14:00 BST Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim™ DRG System

Abbott (NYSE: ABT) today announced the U.S. launch of the company's Proclaim™ DRG Neurostimulator System, a new device designed to deliver...


04 Oct, 2017, 13:00 BST Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc.

Abbott (NYSE: ABT) announced today that it has successfully completed its previously announced tender offer to purchase for cash all outstanding...


27 Sep, 2017, 23:41 BST No More Routine Finger Sticks(1) for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the FreeStyle® Libre Flash Glucose Monitoring System ...


14 Aug, 2017, 13:00 BST Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.

Abbott (NYSE: ABT) announced today that it is extending its previously announced tender offer to purchase for cash all outstanding shares of Series B ...


16 Feb, 2017, 07:00 GMT Real-World Data from Abbott's FreeStyle® Libre Show Association Between Higher Frequency of Glucose Monitoring and Improved Glucose Control for People with Diabetes

Abbott (NYSE: ABT) today announced the results of real-world use data[1] showing that people who scan more frequently using Abbott′s FreeStyle® Libre ...


10 Jan, 2017, 12:00 GMT Abbott Announces CE Mark for its Alinity ci-series Diagnostic Systems

NEXT GENERATION OF HARMONIZED SYSTEMS, COMBINED WITH RECENTLY LAUNCHED ALINIQ PROFESSIONAL SERVICES, PROVIDE A UNIQUE SOLUTION TO HELP LABS AND...


10 Jan, 2017, 12:00 GMT Abbott Announces CE Mark for its "Alinity s" Blood and Plasma Screening System

Abbott (NYSE: ABT) announced today its Alinity™ s System for blood and plasma screening received CE Mark and is now available in Europe and other...


04 Jan, 2017, 21:45 GMT Abbott Completes the Acquisition of St. Jude Medical

Abbott (NYSE: ABT) announced today it has completed the acquisition of St. Jude Medical, Inc., establishing the company as a leader in the medical...


30 Dec, 2016, 17:31 GMT Abbott Acquisition of St. Jude Medical Set to Close on January 4, 2017

Abbott (NYSE: ABT) announced today it intends to close the acquisition of St. Jude Medical, Inc., on Wednesday, Jan. 4, 2017. The announcement...


18 Oct, 2016, 13:00 BST St. Jude Medical and Abbott to Sell Portion of Vascular Closure and Electrophysiology Businesses to Terumo Corporation

Abbott (NYSE: ABT) and St. Jude Medical, Inc. (NYSE: STJ) announced today an agreement in principle to sell certain products to Terumo Corporation....


02 Aug, 2016, 15:00 BST Abbott Unveils Alinity™, its Unified Family of Innovative Next-Generation Diagnostics Systems

Abbott (NYSE: ABT) announced today the introduction of Alinity™, its harmonized family of next-generation systems across immunoassay, clinical...